| Literature DB >> 29116140 |
Christian Kirschneck1, Sarah Batschkus2, Peter Proff3, Josef Köstler4, Gerrit Spanier5, Agnes Schröder3.
Abstract
Meaningful, reliable and valid mRNA expression analyses by real-time quantitative PCR (RT-qPCR) can only be achieved, if suitable reference genes are chosen for normalization and if appropriate RT-qPCR quality standards are met. Human periodontal ligament (hPDL) fibroblasts play a major mediating role in orthodontic tooth movement and periodontitis. Despite corresponding in-vitro gene expression studies being a focus of interest for many years, no information is available for hPDL fibroblasts on suitable reference genes, which are generally used in RT-qPCR experiments to normalize variability between samples. The aim of this study was to identify and validate suitable reference genes for normalization in untreated hPDL fibroblasts as well as experiments on orthodontic tooth movement or periodontitis (Aggregatibacter actinomycetemcomitans). We investigated the suitability of 13 candidate reference genes using four different algorithms (geNorm, NormFinder, comparative ΔCq and BestKeeper) and ranked them according to their expression stability. Overall PPIB (peptidylprolyl isomerase A), TBP (TATA-box-binding protein) and RPL22 (ribosomal protein 22) were found to be most stably expressed with two genes in conjunction sufficient for reliable normalization. This study provides an accurate tool for quantitative gene expression analysis in hPDL fibroblasts according to the MIQE guidelines and shows that reference gene reliability is treatment-specific.Entities:
Mesh:
Year: 2017 PMID: 29116140 PMCID: PMC5677027 DOI: 10.1038/s41598-017-15281-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
RT-qPCR gene, primer and target/amplicon information for the 13 investigated candidate references genes.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| glyceraldehyde-3-phosphate dehydrogenase | enzyme in glycolysis and gluconeo-genesis | NM_002046.5 | 12p13.31 (1421 bp) | TGCCCTCAACGACCACTTTG (20 bp/59.4 °C/55.0%/−0.7/3/2) | CCACCACCCTGTTGCTGTAG (20 bp/61.4 °C/60.0%/0.0/4/2) | exon 8/9 (−2.4) | 74 bp, 50.0%, 84.0 °C, no SSAT | 1091/1164 | Yes (104 bp) | Yes (BLAST /UCSC) | Yes |
|
| peptidylprolyl isomerase A (cyclophilin B) | ER cyclosporine-binding protein | NM_000942.4 | 15q21-q22 (1045 bp) | TTCCATCGTGTAATCAAGGACTTC (24 bp/59.3 °C/41.7%/−1.3/4/2) | GCTCACCGTAGATGCTCTTTC (21 bp/59.8 °C/52.4%/−0.7/4/0) | exon ¾ (−2.1) | 88 bp, 53.4%, 86.1 °C, no SSAT | 446/533 | Yes (3194 bp) | Yes (BLAST /UCSC) | Yes |
|
| tyrosine 3-monoo-xygenase /tryptophan 5-monoo-xygenase activation protein, zeta | signal transduction, apoptotic pathways | NM_003406.3 | 8q23.1 (3003 bp) | AGGAGATTACTACCGTTACTTGGC(24 bp/61.0 °C/46%/0.0/4/2) | AGCTTCTTGGTATGCTTGTTGTG (23 bp/58.9 °C/43%/−3.0/4/0) | exon 8/9 (−2.2) | 91 bp, 47.3%, 84.0 °C, no SSAT | 504/572 | Yes (617 bp) | Yes (BLAST /UCSC) | Yes |
|
| polymerase (RNA) II (DNA directed) polypeptide A, 220 kDa | transcription of DNA into mRNA | NM_000937.4 | 17p13.1 (6738 bp) | TCGCTTACTGTCTTCCTGTTGG (22 bp/60.3 °C/50.0%/0.0/3/0) | TGTGTTGGCAGTCACCTTCC (20 bp/59.4 °C/55.0%/−1.3/3./ 3) | exon 21/22 (−2.5) | 108 bp, 53.7%, 87.8 °C, no SSAT | 3798/3905 | Yes (468 bp) | Yes (BLAST /UCSC) | Yes |
|
| TATA-box-binding protein | general transcription factor | NM_003194.4 | 6q27 (1921 bp) | CGGCTGTTTAACTTCGCTTCC (21bp/59.8 °C/52.4%/−0.8/5/0) | TGGGTTATCTTCACACGCCAAG (22 bp/60.3 °C/50.0%/−1.5/3/2) | exon ½ (−2.4) | 86 bp, 51.2%, 85.6 °C, no SSAT | 79/164 | Yes (2418 bp) | Yes (BLAST /UCSC) | Yes |
|
| ribosomal protein L22 | translation of mRNA in protein | NM_000983.3 | 1p36.31 (2099 bp) | TGATTGCACCCACCCTGTAG (20 bp/59.4 °C/55.0%/−3.4/4/2) | GGTTCCCAGCTTTTCCGTTC (20 bp/59.4 °C/55.0%/−3.0/4/0) | exon 2/3 (−1.5) | 98 bp, 44.9%, 83.8 °C, no SSAT | 115/212 | Yes (4597 bp) | Yes (BLAST /UCSC) | Yes |
|
| eukaryotic translation elongation factor 1 alpha 1 | enzymatic delivery of aminoacyl tRNAs to ribosome | NM_001402.5 | 6q14.1 (3528 bp) | CCTGCCTCTCCAGGATGTCTAC (22 bp/64.0 °C/59.1%/−3.0/5/2) | GGAGCAAAGGTGACCACCATAC (22 bp/62.1 °C/54.6%/−3.2/6/2) | exon 5/6 (−2.9) | 105 bp, 52.4%, 86.5 °C, no SSAT | 804/908 | Yes (87 bp) | Yes (BLAST /UCSC) | Yes |
|
| ribosomal protein, large, P0 | translation of mRNA in protein | NM_001002.3 | 12q24.2 (1229 bp) | GAAACTCTGCATTCTCGCTTCC(22 bp/60.3 °C/50.0%/−3.4/4/0) | GACTCGTTTGTACCCGTTGATG (22 bp/60.3 °C/50.0%/−2.0/4/0) | exon 6/7 (−1.8) | 120 bp, 50.8%, 86.5 °C, no SSAT | 803/921 | Yes (1091 bp) | Yes (BLAST /UCSC) | Yes |
|
| 18S ribosomal 5 | ribosomal RNA, translation of mRNA in protein | NR_003286.2 | 22p12 (1869bp) | AACTGCGAATGGCTCATTAAATCw (23 bp/57.1 °C/39.1%/−1.7/6/3) | GCCCGTCGGCATGTATTAG(19 bp/58.8 °C/57.9%/−2.4/5/1) | (−2.4) | 103 bp, 46.6%, 83.7 °C, no SSAT | 84/186 | No (rRNA) | No(RNA45S5 also targeted) | — |
|
| ubiquitin C | maintains ubiquitin levels under stress (protein removal) | NM_021009.6 | 12q24.3 (2594 bp) | No specific primer pair meeting all criteria could be designed. | — | — | — | — | — | — | |
|
| glucuro-nidase, beta | breakdown of glycosamin-oglycans in lysosomes | NM_000181.3 | 7q21.11 (2321 bp) | No specific primer pair meeting all criteria could be designed. | — | — | — | — | — | — | |
|
| actin, beta | cytoskeletal structural protein | NM_001101.3 | 7p22 (1852bp) | No specific primer pair meeting all criteria could be designed. | — | — | — | — | — | — | |
|
| tubulin, beta class I | cytoskeletal structural protein | NM_001293212.1 | 6p21.33 (2772 bp) | No specific primer pair meeting all criteria could be designed. | — | — | — | — | — | — |
ER = endoplasmic reticulum; Tm = melting temperature of primer/specific qPCR product (amplicon); %GC = guanine/cytosine content; bp = base pairs; Comp. = Complementarity; SSAT = secondary structure at annealing temperature.
Figure 1Specifity of RT-qPCR amplification as determined by (a) melting curve analysis and (b) agarose gel electrophoresis of RT-qPCR products. For each candidate reference gene/primer pair we found a single fluorescent band at the expected amplicon size. bp = base pairs. Gene names see Table 1. All RT-qPCR products were run concurrently and adjacently on the same gel, which was recorded with the gel documentation system Genoplex 2 (VWR International GmbH, Darmstadt, Germany) and its software GenoCapture (version 7.01, Synoptics Ltd., Cambridge, UK - automatic exposure, exposure time 80 ms, no binning, transillumination) as secure gel data (*.sgd) and exported as TIF image, which was inverted and cropped to encompass the relevant gel area. The uncropped original gel is provided as Supplementary Figure 2.
Primer efficiency (factor-specific) and coefficients of determination derived from a standard curve for each primer pair (6x log10 dilution of cDNA stock solution, random untreated sample) as well as technical repeatability (intraassay reliability, n = 18) and amplification efficiency (sample-specific), calculated using LinRegPCR software (http://LinRegPCR.HFRC.nl; n = 18 in triplets).
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| GAPDH | −3.480 | 93.8 (1.916) | 0.9998 | 0.12 0.03/0.24 | 91.1 (1.880) |
| PPIB | −3.509 | 92.7 (1.902) | 0.9996 | 0.13 0.01/0.29 | 90.6 (1.874) |
| YWHAZ | −3.488 | 93.5 (1.912) | 0.9993 | 0.11 0.03/0.32 | 91.3 (1.883) |
| POLR2A | −3.520 | 92.3 (1.897) | 0.9984 | 0.17 0.04/0.35 | 87.3 (1.832) |
| TBP | −3.538 | 91.7 (1.888) | 0.9974 | 0.11 0.02/0.27 | 89.7 (1.862) |
| RPL22 | −3.403 | 96.7 (1.955) | 0.9949 | 0.13 0.02/0.33 | 90.1 (1.868) |
| EEF1A1 | −3.315 | 100.3 (2.004) | 0.9951 |
| 89.5 (1.860) |
| RPLP0 | −3.509 | 92.7 (1.902) | 0.9992 | 0.17 0.05/0.36 | 87.8 (1.838) |
| RNA18S5 | −3.319 | 100.1 (2.002) | 0.9974 | 0.08 0.03/0.20 | 113.4 (2.195) |
*Of three technical replicates (triplet) among all biological replicates (n = 18). CI = confidence interval.
Figure 2Expression levels of candidate reference genes across all experimental groups (n = 18). Values are presented as quantification cycle (Cq, mean of triplicate technical replicates) as second derivative maximum of the fluorescence curve and are inversely proportional to the initial amount of cDNA. Genes are ordered from left (highest expression) to right (lowest expression) according to their mean Cq values. Gene names see Table 1. Boxplots show median, interquartile range (box) and data range (whiskers).
Figure 3GeNorm expression stability analysis of the nine candidate reference genes, for which specific primers could be constructed. (a) Optimal number of reference genes for hPDL RT-qPCR data normalization in orthodontic studies (compressive orthodontic force vs. untreated control, n = 12), studies on periodontitis (Agac toxins vs. untreated control, n = 12) and pooled/overall (n = 18). (b) Average expression stability values of overall (pooled) specimens derived by stepwise exclusion of the least stable reference gene across all specimens and experimental conditions (n = 18). A smaller M value indicates a more stable gene expression. Gene names see Table 1.
Reference gene stability ranking for hPDL experiments on orthodontic tooth movement (compressive orthodontic force vs. untreated control), experiments on periodontitis (Agac, toxins/bacterial lysate vs. untreated control) and pooled/overall experimental conditions as calculated by the algorithms geNorm, NormFinder, comparative ΔCq and BestKeeper.
|
|
|
|
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranking order | Rank sum | Ranking order | Stability value (M) | Ranking order | Stability value (ρig/σi) | Standard error | Ranking order | Stability value (mean SD of mean ∆Cq) | Ranking order | Stability value (r) | SD (+/− Cq) | CV (% Cq) | |
|
| |||||||||||||
| 1.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| 4.) | RNA18S5 | 19 | RPLP0 | 0.255 | RPLP0 | 0.110 | 0.029 | RPLP0 | 0.268 |
|
|
|
|
| 5.) | RPLP0 | 19 | EEF1A1 | 0.269 | EEF1A1 | 0.131 | 0.033 | EEF1A1 | 0.282 |
|
|
|
|
| 6.) | EEF1A1 | 23 | RNA18S5 | 0.305 | RNA18S5 | 0.154 | 0.037 | RNA18S5 | 0.311 | POLR2A | 0.660 | 0.357 | 1.681 |
| 7.) | YWHAZ | 29 | GAPDH | 0.316 | GAPDH | 0.182 | 0.042 | GAPDH | 0.334 | RPLP0 | 0.419 | 0.098 | 0.601 |
| 8.) | GAPDH | 30 | POLR2A | 0.346 | POLR2A | 0.207 | 0.047 | POLR2A | 0.373 | EEF1A1 | 0.388 | 0.114 | 0.814 |
| 9.) | POLR2A | 30 | YWHAZ | 0.385 | YWHAZ | 0.238 | 0.053 | YWHAZ | 0.416 | GAPDH | −0.139 | 0.117 | 0.776 |
|
| |||||||||||||
| 1.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3.) | POLR2A | 14 | EEF1A1 | 0.191 | POLR2A | 0.085 | 0.024 | EEF1A1 | 0.196 |
|
|
|
|
| 4.) | EEF1A1 | 15 | POLR2A | 0.212 | GAPDH | 0.086 | 0.024 |
|
| GAPDH | 0.683 | 0.159 | 1.044 |
| 5.) | GAPDH | 22 | RPLP0 | 0.213 | EEF1A1 | 0.086 | 0.024 | RPLP0 | 0.224 | RNA18S5 | 0.643 | 0.269 | 3.261 |
| 6.) |
|
|
|
|
|
|
| POLR2A | 0.225 | EEF1A1 | 0.641 | 0.167 | 1.170 |
| 7.) | RPLP0 | 24 | GAPDH | 0.216 | RPLP0 | 0.109 | 0.028 | GAPDH | 0.226 | RPLP0 | 0.562 | 0.172 | 1.049 |
| 8.) | RNA18S5 | 29 | RNA18S5 | 0.339 | RNA18S5 | 0.208 | 0.046 | RNA18S5 | 0.347 |
|
|
|
|
| 9.) | YWHAZ | 36 | YWHAZ | 0.399 | YWHAZ | 0.260 | 0.057 | YWHAZ | 0.425 | YWHAZ | 0.266 | 0.318 | 1.488 |
|
| |||||||||||||
| 1.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| 4.) | RPLP0 | 19 | RPLP0 | 0.271 | RPLP0 | 0.122 | 0.026 | RPLP0 | 0.287 | POLR2A | 0.638 | 0.280 | 1.320 |
| 5.) | POLR2A | 22 | EEF1A1 | 0.303 | EEF1A1 | 0.161 | 0.031 | EEF1A1 | 0.313 | YWHAZ | 0.638 | 0.381 | 1.777 |
| 6.) | EEF1A1 | 23 | POLR2A | 0.317 | POLR2A | 0.168 | 0.032 | POLR2A | 0.340 | RPL22 | 0.596 | 0.141 | 0.776 |
| 7.) | RNA18S5 | 23 | GAPDH | 0.335 | RNA18S5 | 0.182 | 0.034 | RNA18S5 | 0.350 | RPLP0 | 0.429 | 0.149 | 0.913 |
| 8.) | YWHAZ | 31 | RNA18S5 | 0.341 | GAPDH | 0.187 | 0.035 | GAPDH | 0.353 | EEF1A1 | 0.399 | 0.181 | 1.277 |
| 9.) | GAPDH | 32 | YWHAZ | 0.440 | YWHAZ | 0.280 | 0.049 | YWHAZ | 0.472 | GAPDH | 0.206 | 0.189 | 1.245 |
A higher rank denotes lower expression stability Cq = quantification cycle; SD = standard deviation; CV = coefficient of variation; r = Pearson’s correlation coefficient.
Figure 4Correlation matrix of the stability values of the four different algorithms used for reference gene evaluation (geNorm, NormFinder, BestKeeper, comparative ΔCq). Scatterplots visualize bivariate correlations of the overall stability values of the nine assessed candidate reference genes as computed by two different algorithms including a linear regression line. r = Pearson’s correlation coefficient; **p ≤ 0.01.
Figure 5Experimental setup for the hPDL fibroblast experiments. (a) 6-well cell culture plate with untreated controls and simulated periodontitis (left side) as well as simulated orthodontic compressive force (right side). (b) Experimental conditions tested (physiological cell culture conditions): untreated physiological controls (adherently growing hPDL cells at 70% confluence in full medium), simulated orthodontic compressive force of 2 g/cm2 applied by a 17.1 g glass disc, simulated periodontitis by adding bacterial lysate (toxins) of Aggregatibacter actinomycetemcomitans to the medium.